What do we mean by Nebuliser Therapy?
Nebulised inhalation is a method of drug administration directly to the respiratory system. Nebulisers are the devices used to convert liquids into aerosols of a size that can be inhaled into the lower respiratory tract.
The advantage of inhaled aerosols is that they allow selective treatment for the lungs by achieving high drug concentrations in the airway while reducing systemic adverse effects. In addition, inhaled bronchodilators produce a more rapid onset of action than oral delivery because of the large surface area of the lung (70 to 80 m2) that allows a rapid absorption.
Nebuliser therapy is an important administration route in the treatment of lung diseases like asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and bronchopulmonary dysplasia (BPD).
Improving patient outcomes with a nebuliser service
Healthcare policy has raised the profile of long-term conditions and emphasis is now placed on providing care closer to home. Whilst there has been greater recognition that healthcare needs to target those most in need, reports over the past five years have highlighted the shortfall (Healthcare Commission 2006, RCP COPD Audit 2008, BLF 2012). This has led to the development of the recently published National Strategy on COPD (2010) which aims to improve the quality of and access to COPD services, reduce health inequalities and improve healthcare utilisation costs. The Home Nebuliser Service provided by Baywater Healthcare contributes to these aims and conforms to those stated in the 2012 NHS Outcomes Framework.